Unlike mammals, adult zebrafish undergo spontaneous recovery after major spinal cord injury.
INTRODUCTION
Traumatic spinal cord injuries (SCI) are incurable conditions that require long-term therapeutic, rehabilitative, and psychological interventions. Following SCI, primary neuronal loss triggers cascades of secondary damages in the mammalian spinal cord (SC). Scarring, neurotoxicity, and inherent resistance to axon growth and neurogenesis continue to present major hurdles to SC regenerative medicine.
In contrast to mammals, elevated regenerative capacity enables adult zebrafish to reverse paralysis within 6-8 weeks of complete SC transection [1, 2] . Zebrafish elicit efficient proregenerative injury responses including axon regrowth, neurogenesis, and absence of scarring [2] [3] [4] . These regenerative processes distinguish the zebrafish SC from mammalian SCs and enable its natural repair post-injury. Following SC transection in zebrafish, a group of specialized glial cells bridge the SC, and axons are believed to regrow along these bridging glia [1, 2] . Glial bridging is a natural regenerative mechanism that could be deployed to support axon growth across species. Translating this regenerative process into regenerative therapies requires a comprehensive understanding of the cell fates and molecular mechanisms that lead to the emergence of bridging glial cells after SCI.
We previously identified connective tissue growth factor a (ctgfa) as a pro-regenerative bridging factor in zebrafish [1] . Ctgf is a secreted, extracellular molecule that elicits various cellular responses including proliferation and differentiation. The spatiotemporal pattern of ctgfa expression correlates with glial bridge formation in zebrafish. Following SCI, ctgfa expression is first broadly induced within ependymo-radial glial cells (ERGs), which line the central canal proximal to both ends of the lesion. During subsequent steps of regeneration, ctgfa transcripts localize to bridging glial cells and surrounding cells at the lesion core, and to ventral ERGs that are thought to give rise to bridging glia. Genetic mutants in zebrafish ctgfa demonstrated its requirement during bridging and regeneration; whereas genetic and pharmacologic ctgfa overexpression proved sufficient to promote bridging and functional SC repair. These findings implicated Ctgf as a central player in SC bridging, and importantly, enabled us to generate a battery of Ctgf-based tools to decipher cell identities and molecular mechanisms during glial bridging in zebrafish.
The transcriptional co-activators Yes-associated protein (Yap) and transcriptional co-activator with PDZ-binding motif (Taz) are downstream co-activators of Hippo signaling, regulating cell plasticity and organ growth during development and regeneration. Yap and Taz lack DNA-binding domains and control transcription by association with the Tead DNA-binding transcription factors to promote cell proliferation and maintenance of stem cell fate [5, 6] . Ctgf is a direct target of Yap/Taz signaling in multiple tissue contexts, and it remains to be determined whether Yap signaling is activated and whether Yap activation regulates Ctgf expression and glial bridging after SCI in zebrafish.
Unlike CNS injuries, peripheral nerve injuries elicit pro-regenerative responses in mammals.
Axon regrowth and myelination of regenerating axons enable functional repair after nerve injury.
Glial cell injury responses are central to this regeneration process and involve the activation of a repair program by differentiated Schwann cells. Following transection injuries that generate a gap in the mammalian nerve, repair Schwann cells migrate into the lesion site, bridge the severed ends of the nerve, and guide regenerating axons through the nerve bridge to support distal innervation [7, 8] . Repair Schwann cells execute these regenerative functions by upregulating EMT-associated genes during nerve regeneration, which result in partial cellular reprogramming from an epithelial cell fate to a more plastic mesenchymal fate [9, 10] . The Twist, Zeb, Snail, and Slug transcription factors are known to control EMT by downregulating cell-cell adhesion molecules, instigating loss of cell polarity, while elevating proliferative and migratory capacities.
EMT is thus often linked to increased plasticity and stem cell activation during tissue regeneration.
Bridging Schwann cells of the mammalian PNS share morphological and functional similarities with bridging glial cells of the zebrafish CNS [1, 7] . Yet, the extent of molecular similarities between these pro-regenerative glia remains to be determined.
Here, we used a battery of ctgfa-based genetic tools 1) to define the transcriptional profiles of bridging glial cells in zebrafish, 2) to determine the early injury-responses that direct ctgfamediated bridging, and 3) to elucidate molecular mechanisms that enable glial bridging. To these ends, we generated transgenic ctgfa/gfap dual reporter line to isolate and deep sequence ctgfa + gfap + cells. The transcriptional profiles of zebrafish bridging glia shared similarities with the Repair Schwann cells that bridge transected nerves in the mammalian PNS. We identified a Yap-Ctgf-EMT signaling axis that directs glial bridging and functional regeneration. Yap activation correlates with ctgfa expression and is required for bridging and functional SC repair. Regulation of ctgfa expression converges onto a 1Kb cis-regulatory element that directs ctgfa-dependent transcription following injury. Yap-Ctgf signaling upregulates twist and zeb transcription factors, which in turn promote partial EMT and support SC regeneration. Our findings unraveled the molecular identity of bridging glial cells in zebrafish and revealed a previously unrecognized gene regulatory network that directs glial bridging following SCI.
RESULTS

Molecular profiling of ctgfa + gfap + bridging glial cells after spinal cord injury.
We devised a Fluorescence Activated Cell Sorting and RNA deep sequencing (FACS-seq) strategy to profile the transcriptome of bridging glial cells using Ctgfa and Gfap (Fig. 1 ). Ctgfa expression was previously shown to demarcate bridging glia at the lesion core and their predicted progenitors in the ventral ependyma proximal to the lesion [1] . To specifically label bridging glia, we generated transgenic -5.5Kb-ctgfa:mCherry reporter line in combination with the previously established gfap:EGFP transgene (mi2002, [11] ) ( Fig 1A) . Broadly expressed in developing zebrafish animals, ctgfa-driven mCherry expression co-localized with gfap:EGFP in the ventral floor plate at 5 days post-fertilization ( Fig. S1A ). Consistent with its injury-induced expression, mCherry expression was not detectable in unlesioned adult SCs but was upregulated within SC tissue after injury ( Fig. S1B ). Longitudinal SC sections from adult ctgfa:mCherry;gfap:EGFP animals confirmed mCherry and EGFP expression in bridging glia as early as 5 days post-injury (dpi) ( Fig. 1 A, B ). mCherry expression was also broadly induced in gfap + ependymal progenitors at 1 wpi (Fig. S1B) , and localized to ventral ependymal cells at 10 dpi ( Fig. 1 A, B) . These results recapitulated the expression patterns of endogenous ctgfa transcripts and of a previously established -5.5Kb-ctgfa:EGFP reporter line after SCI [1] . Thus, we used the ctgfa/gfap dual reporter line to isolate ctgfa + gfap + glial cells.
To define the molecular signature of pro-regenerative bridging glia, we performed FACS-seq on ctgfa + gfap + cells and bulk SC tissue ( Fig. 1 C-E). Complete SC transection was performed on ctgfa/gfap dual reporter animals. Single reporters and wild type animals were used as controls.
At 5 dpi, 2 mm SC tissue samples including the lesion site were harvested and dissociated for FACS sorting. As a negative control, we collected SC tissue from sham injured animals (data not shown). From these experiments, we were able to collect mCherry + EGFP + cells from animals with transected SCs but not from sham-injured animals. These results confirmed the injury-induced nature of Ctgfa and the emergence of ctgfa + gfap + cells after injury. mCherry + EGFP + cells comprised ~3% of the total dissociated cells at 5 dpi, while ~60% of the cells showing exclusive EGFP expression ( Fig. 1 C) . RNA samples from isolated ctgfa + gfap + cells and bulk SC tissue at 5 dpi were deep sequenced. SC tissue samples from 10 and 21 dpi as well as uninjured control samples were also sequenced ( Fig. 1 
D, E). Principle component and heat map analyses revealed
clustering of biological replicates, and highlighted the extent of molecular regeneration between 5, 10 and 21 dpi relative to control samples. We next performed differential gene expression analysis to explore molecular mechanisms of glial bridging ( Fig. 1 E) . As predicted by sorting mCherry + EGFP + cells, our FACS-seq approach enriched for ctgfa expression ( Fig. 1 E) . ctgfa is expressed in multiple cell types around the lesioned SC; yet, its expression is primarily confined to bridging glia and ventral ependymal progenitors within dissected SC tissue. We thus observed elevated ctgfa expression in ctgfa + gfap + cells relative to bulk SC tissue. Conversely, gfap is expressed in ~60% of the total cells dissociated from SC tissue, and Ctgfa + cells constitute only a minor subset of Gfap expressing cells. Consequently, gfap expression was attenuated in isolated ctgfa + gfap + cells relative to bulk SC tissue. We also observed that neuronal and oligodendrocyte markers, such as neurod1 and mbpb, were depleted in isolated ctgfa + gfap + cells, suggesting that isolated ctgfa + gfap + cells were depleted of neurons and oligodendrocytes. These studies generated the first transcriptional blueprints for pro-regenerative bridging glia in adult zebrafish.
Yap is activated in Ctgfa-expressing cells after spinal cord injury.
The Hippo signaling pathway and its downstream co-activators Yap and Taz play important roles in injury response and tissue regeneration in multiple tissue contexts. Similar to ctgfa expression after SCI, the Yap target genes, cyr61 and gli2a, were upregulated in bulk SC tissue and enriched in isolated ctgfa + gfap + cells at 5 dpi relative to uninjured controls ( Fig. 2 A) .
Moreover, yap1, taz, and their transcription factor effectors tead1a and tead1b were upregulated in injured SC tissue ( Fig. 2A ). However, while taz was ~2-fold enriched in isolated ctgfa + gfap + cells, yap1 and the tead transcription factors were only mildly enriched by FACS-seq, reflecting their ubiquitous expression pattern across multiple SC cell types. These gene expression studies suggested that Yap signaling is activated upstream of Ctgfa during glial bridging.
To further examine Yap and Taz activation after SCI, we performed immunohistochemistry on on wild-type SCs at 1, 2, and 3 wpi as well as uninjured controls ( Fig. 2 
A 1Kb enhancer element directs ctgfa expression after SCI.
Ctgfa is a target of Yap signaling in multiple tissue contexts, yet it remains unclear whether similar regulatory mechanisms applied during SC regeneration. We performed a comprehensive analysis of the cis-regulatory elements that direct injury-induced ctgfa expression in regenerating SC tissue ( Fig. 3 A) . Using -5.5Kb-ctgfa:EGFP, we previously showed that EGFP fluorescence recapitulates endogenous mRNA expression in ventral ependymal progenitors and in bridging glia during SC regeneration [1] . Bioinformatics analysis of the 5.5 Kb genomic region revealed predicted binding sites for Tead transcription factors 3 to 4 Kb upsteam of ctgfa translational start site ( Fig. S4 ). Stable transgenic lines expressing an EGFP cassette downstream of the -4Kb-or -3Kb genomic regions were generated (-4kb-ctgfa:EGFP and -3kb-ctgfa:EGFP, respectively) ( Fig.   3A ). Multiple independent lines were generated for each transgene to control for possible positional effects that may impact transgene expression. At 10 dpi, ctgfa-driven EGFP and Gfap expression were assessed 100 µm (proximal) and 500 µm (distal) rostral to the lesion ( Fig. 3 B) .
Similar to -5.5Kb-ctgfa:EGFP, only -4Kb-ctgfa:EGFP transgenic lines showed EGFP expression at 10 dpi; while EGFP expression was not detectable in -3Kb-ctgfa:EGFP lines ( Fig. 3 C, D) .
These results suggested that cis-regulatory elements located between 3 and 4 Kb upstream of the ctgfa translational start site direct ctgfa expression after SCI. To determine whether this putative 1Kb enhancer element is sufficient to promote EGFP expression after SCI, we generated 1Kb-ctgfa:EGFP transgenic line and examined EGFP expression following injury. EGFP was not detectable in uninjured controls, but was comparable to -5.5Kb-and -4Kb-ctgfa:EGFP expression at 10 dpi ( Fig. 3 C, D) . This expression pattern was recapitulated in three independent lines of the 1Kb-ctgfa:EGFP transgene (Fig. S5) . These results revealed a 1Kb enhancer element that directs injury-induced ctgfa expression after SCI.
Yap is required for Ctgfa expression and for functional SC repair.
To determine the effects of Yap inactivation, we expressed dominant negative Yap under control of a heat-inducible promoter (hsp70:dsRed-dnYap) ( Fig. 4 ). We first combined dnYap expressing and -5.5Kb-ctgfa:EGFP transgenes to examine ctgfa-driven EGFP expression upon Yap inactivation. hsp70:dsRed-dnYap;ctgfa:EGFP (Tg + ) zebrafish and ctgfa:EGFP (Tg -) controls were subjected to SC transections followed by daily heat shocks to induce dnYap expression.
EGFP expression was observed in ventral ependymal progenitors of ctgfa:EGFP controls at 10 dpi, but was attenuated in dnYAP-expressing animals ( Fig. 4 A) . Quantification showed a significant decrease in EGFP expression in the ventral SCs of dnYap-expressing animals relative to their control siblings ( Fig. 4 B) . These results indicated that Yap promotes ctgfa expression in ventral ependymal progenitors after SCI.
We then assessed the outcomes of Yap inactivation on functional and anatomical SC repair E). We next examined glial bridging at earlier bridging stages to assess glial bridging defects upon dnYap expression ( Fig. 4 F, G) . At 10 dpi, Gfap immunostaining revealed the formation of an organized circular bridge at the lesion core. However, the glial bridges formed upon dnYap expression were 50% reduced and irregularly shaped relative to controls. These results revealed that Yap promotes glial bridging and functional SC repair.
Localized EMT directs glial bridging downstream of Ctgfa.
Ctgf proteins exert diverse functions by binding various cell surface receptors, growth factors, and extracellular matrix proteins [12] . By FACS-seq, twist1a and zeb2a transcription factors are upregulated in ventral ependymal progenitors at 5 dpi ( Fig. 5 A) . in situ hybridization confirmed that twist1a transcripts showed elevated expression in ventral ependymal progenitors at 2 wpi, ( Fig. 6 B) . Localized treatment with human recombinant C-terminal CTGF (CTGF-CT), which is sufficient to promote glial bridging and functional regeneration [1] , induces ectopic Twist expression in ependymal cells at 2 wpi ( Fig. 6 C) . These experiments indicated that the transcription factor twist1a is a downstream effector of ctgfa during glial bridging, and suggested that twist and zeb transcription factors drive EMT downstream of Yap-Ctgf signaling after SCI.
twist1 and zeb2 are key transcription factor effectors of EMT. Hallmarks of EMT include concomitant downregulation of epithelial E-Cadherin (Cdh1) and upregulation of N-cadherin (Cdh2). We found that cdh1 is depleted in isolated ctgfa + gfap + cells at 5 dpi despite its upregulation in bulk SC tissue after SCI ( Fig. 5 A) . cdh2 is expressed isolated ctgfa + gfap + cells, suggesting these cells are undergoing a transition into mesenchymal cell fate. Additional mesenchymal markers, snai1a and snai2, are upregulated in injured SC tissue and enriched in bridging glia at 5 dpi. By immunohistochemistry, Cdh1 was specifically downregulated in ctgfa + cells at 1 and 2 wpi ( Fig. 5 D) . Cdh1 expression was increased in lateral ERGs at these time points, and broadly attenuated toward baseline expression by 3 wpi. On the other hand, Cdh1
and Vim showed dynamic gene expression changes after SCI. High levels of Cdh1 expression were detectable in ctgfa + cells at 1 and 2 wpi. Vimentin was globally upregulated at 1 wpi, showed preferential expression in ventral ependymal progenitors at 2 wpi, and localized to the progenitor motor domain by 3 wpi (Fig. S6) . These results are consistent with the FACS-seq data and suggested that ctgfa + cells undergo a mesenchymal transition during glial bridging.
DISCUSSION
This study defines the transcriptional profiles of bridging glial cells in zebrafish, and found that Yap-Ctgf-EMT signaling axis mediates localized injury-responses and directs glial bridging after SCI. Using newly generated ctgfa/gfap dual reporter line, we isolated and deep sequenced ctgfa + gfap + cells. Yap nuclear localization, Ctgf expression, and EMT markers impinge on ventral ependymal progenitors, instructing a glial bridging cell fate that supports innate regeneration in zebrafish. We show that Yap promotes Ctgfa expression, glial bridging and functional SC repair, and that Ctgfa regulation is driven by a 1Kb regeneration enhancer that drives its expression after SCI. Yap-Ctgf signaling activates Twist driven EMT during glial bridging and SC regeneration.
Glial cell responses are thought to dictate SCI outcomes across species. Following SC transection in zebrafish, specialized glial cells connect the severed SC ends, and axons regrow along these bridging glia [1] . From a translational standpoint, we envision shifting mammalian glia towards a bridging phenotype to abate scarring and support axon regrowth. Practically, this outcome requires detailed understanding of the cells and molecules that induce glial bridge formation. Our study uncovered molecular signature of bridging glial cells in zebrafish. We found that glial bridging shares morphological and molecular hallmarks with Schwann cell mediated and MAPK pathways. Of high relevance to tissue injury and regeneration, Yap is a mechanoresponsive signaling pathway that relays cellular stress into transcriptional responses [13] . One of Yap's mechanosensing functions is to survey the levels of filamentous F-actin, and manipulating F-actin levels is sufficient to shuttle Yap into or out of the nucleus [14] . Active Yap signaling maintains stemness in various stem cell types, including neural and glial progenitors [15] . Yap inactivation promotes stem cell differentiation, while Yap activation is sufficient to revert differentiated cells back to a tissue-specific stem/progenitor cell state [16] . Complete SC Our studies shed light on glial bridging as an effective, natural mechanism of SC repair.
Equipped with a superior regenerative capacity relative to the mammalian CNS, zebrafish SCs trigger pro-regenerative responses that include glial cell activation and EMT-driven bridging following injury. We expect further investigation into bridging glial cell fate to springboard translational applications to improve bridging and regeneration in the mammalian CNS. 
Materials and Methods
Zebrafish.
Adult zebrafish of the Ekkwill strain were maintained as previously described. Male and female animals between 3 and 9 months of ~2 cm in length were used. Different manipulations (e.g. heat shock) can lead to different regeneration and recovery kinetics. Therefore, clutchmate control and experimental fish of similar size and equal sex distribution were used for all experiments. Spinal cord transection surgeries and regeneration analyses were performed in a blinded manner, and independent experiments were repeated using different clutches of animals. Newly constructed strains are described below.
Generation of transgenic ctgfa:mCherry zebrafish. The following primers were used to amplify a 5.5 kb genomic DNA region upstream of the ctgfa translational start site: ClaI forward primer 5'atcgattttggctactttcagctaagactgg-3' and ClaI reverse primer 5'-atcgattctttaaagtttgtagcaaaaagaaa-3'. The genomic fragment was cloned into PCR2.1-TOPO vector, then subcloned into ClaI digested PCS2-mCherry-Nitroreductase plasmid to generate ctgfa:mCherry-Nitroreductase clone. The clone was co-injected into one-cell stage wild-type embryos with I-SceI. Three founders were isolated and propagated. This line is referred to hereafter as ctgfa:mCherry, and the inducible Nitroreductase cassette was not used in this study. The full name of this line is Tg(ctgfa:mCherry-NTR). ctgfa:mCherry animals were analyzed as hemizygotes, or crossed into gfap:EGFP transgene (mi2002, [11] ) to generate ctgfa:mCherry; gfap:EGFP animals.
FACS sorting and RNA sequencing.
Two mm SC sections, including the lesion site plus additional rostral and causal tissue proximal to the lesion, were collected from adult injured zebrafish at 5 dpi. Control tissue sections were collected from uninjured siblings. Wild type animals, ctgfa:mCherry, and gfap:EGFP animals were lesioned and dissociated as additional controls to set up FACS sorting gates. Tissues were dissociated using Trypsin and FACS sorted using a MoFlo Cell sorter. Total RNA was prepared using Tri reagent (Sigma). Total RNA was also directly prepared from two mm SC sections at 5, 10, 21 dpi, and from uninjured controls for bulk RNA-sequencing. TruSeq libraries were prepared in duplicate and sequenced on Illumina HiSeq 2000 using 50 bp single-end reading strategy.
Quality QC and trimming of adapters and short sequences were performed using Fastx.
Sequencing reads were then mapped to the zebrafish genome (Zv11) using Bowtie2, then assembled and quantified using the Cufflinks and Cuffdiff algorithms (22). RNA sequencing was performed and analyzed by the Bioinformatics Core at the Center for Regenerative Medicine at Washington University.
Spinal cord transection and treatment.
Zebrafish were anaesthetized using MS-222. Fine scissors were used to make a small incision that transects the spinal cord 4 mm caudal to the brainstem region. Complete transection was visually confirmed at the time of surgery. Injured animals were also assessed at 2 or 3 dpi to confirm loss of swim capacity post-surgery.
For recombinant CTGF treatment, sterile Gelfoam Absorbable Gelatin Sponge (Pfizer 09-0315-08) was cut into 1 mm3 pieces, soaked with either vehicle or recombinant CTGF peptides (HR-CTGF-CT, eBioscience, 14-8503-80), then cut into 4-6 smaller pieces. At 5 and 10 days postinjury, zebrafish were anaesthetized using MS-222. Fine scissors were used to make a longitudinal incision lateral and parallel to the spinal cord. Injured SC tissues were exposed without causing secondary injuries and gelfoam sponges were placed adjacent to the lesion site.
The incision was closed and glued using Vetbond tissue adhesive material.
Histology.
Sixteen μm cross or 20 μm longitudinal cryosections of paraformaldehyde-fixed SC tissues were used. Tissue sections were imaged using a Zeiss AxioVision compound microscope (for in situ hybridization) or a Zeiss LSM 800 confocal microscope (for immunofluorescence).
in situ hybridization probes for twist1a were subcloned after amplification from 2 dpf zebrafish cDNA into PCR2.1-TOPO vectors (twist1a forward primer 5'-tgtgattgctctgctgttcc-3', twist1a reverse primer 5'-ggtgaggcgattagcttctg-3'). Linearized vectors were used to generate the digoxygenin labeled cRNA probes. in situ hybridizations were performed as previously described (REF) . Primary antibodies used in this study were rabbit anti-GFAP (Sigma, G9269, 1:1000), mouse anti-GFAP (ZIRC, Zrf1, 1:1000), and mouse anti-acetylated-α-tubulin (Sigma, T6793, 1:1000). Secondary antibodies (Invitrogen, 1:200) used in this study were Alexa Fluor 488, Alexa Fluor 594 goat anti-rabbit or anti-mouse antibodies. GFAP immunohistochemistry was performed on serial longitudinal sections. The diameter of the glial bridge and the diameter of the intact spinal cord rostral to the lesion were measured using ImageJ software. Bridging was calculated as a ratio of thesemeasurements. For each fish, percent bridging was calculated for the 3 longitudinal sections that show the most prominent bridging. Percent bridging was then averaged for each cohort. Mann Whitney tests were performed using Prism software to determine statistical significance between groups.
Swim capacity assays.
Zebrafish were exercised in groups of 8-12 in a 5L swim tunnel respirometer device (Loligo, cat#SW100605L, 120V/60Hz). After 5 minutes of acclimation inside the enclosed tunnel, water current velocity was increased every two minutes and fish swam against the current until they reached exhaustion. Exhausted animals were removed from the chamber without disturbing the remaining fish, while others continued to swim. Swim time and current velocity at exhaustion were recorded. Results were expressed as means ± SEM. An unpaired two-tailed Student's t-test with Welch correction was performed using the Prism software to determine statistical significance of swim times between groups.
Axon tracing.
Anterograde axon tracing was performed on adult fish at 4 wpi. Fish were anaesthetized using MS-222 and fine scissors were used to transect the cord 4 mm rostral to the lesion site. Biocytinsoaked Gelfoam Gelatin Sponge was applied at the new injury site (Gelfoam, Pfizer, 09-0315-08;
Biocytin, saturated solution, Sigma, B4261). Fish were euthanized 6 hours post-treatment and Biocytin was histologically detected using Alexa Fluor 594-conjugated Streptavidin (Molecular Probes, S-11227). Biocytin-labeled axons were quantified using the "threshold" and "particle analysis" tools in the ImageJ software (26). Four sections per fish at 0.5 (proximal) and 2 (distal) mm caudal to the lesion core, and 2 sections 1 mm rostral to the lesion, were analyzed. Axon growth was normalized to the efficiency of Biocytin labeling rostral to the lesion for each fish. The axon growth index was then normalized to the control group for each experiment. Mann-Whitney tests were performed using Prism software to determine statistical significance between groups.
